Questionnaire Survey of Neurointerventional Simulation Training in the Japanese Society for Neuroendovascular Therapy.
neurointervention
questionnaire survey
simulation training
Journal
Journal of neuroendovascular therapy
ISSN: 2186-2494
Titre abrégé: J Neuroendovasc Ther
Pays: Japan
ID NLM: 101488164
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
09
2022
accepted:
29
06
2023
medline:
21
9
2023
pubmed:
21
9
2023
entrez:
21
9
2023
Statut:
ppublish
Résumé
Simulation training has focused on education and practical training. However, the adoption rate of neurointerventional simulation training in Japan is unknown. Therefore, we sent a questionnaire survey form to consulting specialists from the Japanese Society for Neuroendovascular Therapy (JSNET) to clarify the actual simulation training situation and compare the differences between university hospitals and general hospitals in Japan. The questionnaire survey was conducted in 243 neurosurgical training facilities that had JSNET consulting specialists between May 31, 2021 and July 31, 2021. The questionnaire survey forms were distributed by Google Forms. A total of 162 facilities responded to the survey (response rate: 66.7%; 35.2% from university hospitals and 64.8% from general hospitals). The adoption rate for simulation training was 53.7%, and it was significantly higher in the university hospitals than in the general hospitals (64.9% vs. 47.6%, The adoption rate for simulation training was 53.7% in the training facilities of JSNET, and it was higher in the university hospitals than in the general hospitals. Most of the respondents answered that simulation training is an effective tool to improve neurointerventional skills. They also requested the establishment of simulation training programs and simulation tools.
Identifiants
pubmed: 37731468
doi: 10.5797/jnet.ra.2022-0062
pii: jnet.ra.2022-0062
pmc: PMC10508991
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
181-187Informations de copyright
©2023 The Japanese Society for Neuroendovascular Therapy.
Déclaration de conflit d'intérêts
Isao Date received research funding from Momotaro-Gene Inc. Kenji Sugiu received a lecture fee from Medtronic and Terumo. The other authors have no conflict of interest.
Références
Neurosurgery. 2020 Sep 15;87(4):E445-E453
pubmed: 32392300
Neurosurg Focus. 2022 Aug;53(2):E4
pubmed: 35916087
Neurosurg Focus. 2020 Mar 1;48(3):E6
pubmed: 32114562
J Neurointerv Surg. 2021 Mar;13(3):251-254
pubmed: 32669397
J Vasc Surg. 2004 Dec;40(6):1118-25
pubmed: 15622365
J Neurointerv Surg. 2019 Sep;11(9):924-930
pubmed: 30992395
PLoS One. 2020 Sep 17;15(9):e0238952
pubmed: 32941466
J Surg Educ. 2021 Sep-Oct;78(5):1644-1654
pubmed: 33487586
World Neurosurg. 2013 Nov;80(5):e1-8
pubmed: 23182732
J Vis Exp. 2020 May 6;(159):
pubmed: 32449712
J Neurointerv Surg. 2012 Nov;4(6):438-41
pubmed: 22015637
World Neurosurg. 2022 Mar;159:e113-e119
pubmed: 34896354
J Cerebrovasc Endovasc Neurosurg. 2021 Mar;23(1):16-22
pubmed: 33530677
J Neurosurg. 2016 May;124(5):1250-6
pubmed: 26381253
Neurol Med Chir (Tokyo). 2013;53(5):347-51
pubmed: 23708228
Comput Biol Med. 2016 Oct 1;77:59-63
pubmed: 27521515
J Neurointerv Surg. 2018 May;10(5):500-504
pubmed: 28814528
Clin Neuroradiol. 2021 Jun;31(2):465-473
pubmed: 32303789
Neurol Med Chir (Tokyo). 2019;59(Spec):13-81
pubmed: 30651422